dc.contributor
Institut Català de la Salut
dc.contributor
[Cuende N] Coordinación Autonómica de Trasplantes de Andalucía, Servicio Andaluz de Salud, Sevilla, Spain. [Vilarrodona A, Querol S] Banc de Sang i Teixits, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Vuelta E] Establecimiento de Tejidos Humanos, Fundación Clínica San Francisco, León, Spain. [Marazuela R] Organización Nacional de Trasplantes, Madrid, Spain. [Herrera C] UGC de Hematología y Unidad de Terapia Celular, Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba, Córdoba, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Cuende, Natividad
dc.contributor.author
Vilarrodona, Anna
dc.contributor.author
Vuelta, Elena
dc.contributor.author
Marazuela, Rosario
dc.contributor.author
Herrera, Concha
dc.contributor.author
Querol Giner, Sergi
dc.date.accessioned
2025-10-24T08:50:59Z
dc.date.available
2025-10-24T08:50:59Z
dc.date.issued
2023-06-20T11:47:58Z
dc.date.issued
2023-06-20T11:47:58Z
dc.identifier
Cuende N, Vilarrodona A, Vuelta E, Marazuela R, Herrera C, Querol S, et al. Addressing Risks Derived From the Commodification of Substances of Human Origin: A European Proposal Applicable Worldwide. Transplantation. 2023 Apr;107(4):867–77.
dc.identifier
https://hdl.handle.net/11351/9823
dc.identifier
10.1097/TP.0000000000004527
dc.identifier.uri
http://hdl.handle.net/11351/9823
dc.description.abstract
Commodification; Human substances
dc.description.abstract
Mercantilització; Substàncies humanes
dc.description.abstract
Mercantilización; Sustancias humanas
dc.description.abstract
In view of the public consultation recently launched by the World Health Organization on Regulatory Convergence of Cell and Gene Therapy Products and the Proposal for a Regulation on substances of human origin (SoHO) repealing the European Union Directives on Blood and on Tissues and Cells, an opportunity arises to define an ethical and transparent framework of collaboration between industry and authorities responsible for SoHO-derived products, comprising medicines, medical devices, transfusion, and transplantation. The commodification of SoHO-derived medicinal products and medical devices entails important risks to the sustainability of healthcare systems and threatens the equitable access of patients to innovative therapies. It may also jeopardize the principle of altruistic donation of SoHO that is required for the treatment and survival of thousands of patients every year. This article puts forward several proposals aimed at reconciling the ethical principles of voluntary and unpaid SoHO donation and the noncommercialization of the human body with obtaining a profit that allows business activities, while ensuring high quality, safety, and efficacy standards of tissues and cells for clinical use.
dc.format
application/pdf
dc.publisher
Wolters Kluwer Health
dc.relation
Transplantation;107(4)
dc.relation
http://dx.doi.org/10.1097/TP.0000000000004527
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Donants de sang
dc.subject
Productes biològics
dc.subject
Mercantilització
dc.subject
TECHNOLOGY, INDUSTRY, AND AGRICULTURE::Technology, Industry, and Agriculture::Commerce::Commodification
dc.subject
CHEMICALS AND DRUGS::Complex Mixtures::Biological Products
dc.subject
NAMED GROUPS::Persons::Tissue Donors::Blood Donors
dc.subject
TECNOLOGÍA, INDUSTRIA Y AGRICULTURA::tecnología, industria y agricultura::comercio::mercantilización
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::mezclas complejas::productos biológicos
dc.subject
DENOMINACIONES DE GRUPOS::personas::donantes de tejidos::donantes de sangre
dc.title
Addressing Risks Derived From the Commodification of Substances of Human Origin: A European Proposal Applicable Worldwide
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
